PHAR Competitors & Alternatives
Compare Pharming Group NV with similar stocks in the same industry
Biotechnology
PHAR
Main Stock$16.36
Tradestie Score
51
Market Cap
$1.05B
P/E Ratio
423.0
Revenue Growth
0.2%
Analyst Upside
+111.6%
Top Competitors
224 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
NUVB
Nuvation Bio Inc.
|
$4.34
|
$1.27B | - | 53 | Compare |
|
SION
Sionna Therapeutics, Inc. Common Stock
|
$37.43
|
$1.26B | - | 51 | Compare |
|
CVAC
CureVac N.V. Ordinary Shares
|
$4.66
|
$1.22B | 7.0 | 58 | Compare |
|
ATAI
ATAI Life Sciences N.V. Common Shares
|
$4.12
|
$1.22B | - | 54 | Compare |
|
PGEN
Precigen, Inc. Common Stock
|
$4.12
|
$1.18B | - | 58 | Compare |
|
ELVN
Enliven Therapeutics, Inc. Common Stock
|
$42.40
|
$1.17B | - | 57 | Compare |
|
INVA
Innoviva, Inc. Common Stock
|
$23.05
|
$1.15B | 7.1 | 62 | Compare |
|
TRVI
Trevi Therapeutics, Inc. Common Stock
|
$13.82
|
$1.14B | - | 54 | Compare |
|
ORIC
Oric Pharmaceuticals, Inc. Common Stock
|
$9.44
|
$1.14B | - | 56 | Compare |
|
MAZE
Maze Therapeutics, Inc. Common Stock
|
$25.68
|
$1.13B | - | 49 | Compare |
More PHAR Analysis
Data updated: Apr 29, 2026 | Industry: Biotechnology (SIC 2834)
224 stocks in this industry